Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 9,10-seco- cyclopentanohydrophenanthrene ring system doai
Patent
1996-08-21
2000-10-17
Moezie, Minna
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
9,10-seco- cyclopentanohydrophenanthrene ring system doai
A61K 3159
Patent
active
06133250&
ABSTRACT:
Method of increasing activated vitamin D blood level by administering orally a 1.alpha.-hydroxyprevitamin D. This previtamin D form increases vitamin D blood level without significant risk of hypercalcemia associated with other oral dosing of vitamin D forms. The 1.alpha.-hydroxyprevitamin is compounded into a pharmaceutical composition in combination with a pharmaceutically acceptable excipient.
REFERENCES:
patent: 2216719 (1940-10-01), Boer
patent: 2434015 (1948-01-01), Rosenberg et al.
patent: 4230701 (1980-10-01), Holick et al.
patent: 4335120 (1982-06-01), Holick et al.
patent: 4505906 (1985-03-01), De Luca et al.
patent: 4539153 (1985-09-01), Vandewalle et al.
patent: 4728643 (1988-03-01), Holick et al.
patent: 5013728 (1991-05-01), Grodberg
E. Brauwald et al., Harrison's Principles of Internal Medicine : Part Eleven, "Disorders of Bone & Mineral Metabolism," Chapter 335, (eds.) McGraw-Hill, New York (1987) pp. 1860-65.
M. L. Curtin and W. H. Okamura, J. Am. Chem. Soc., vol. 113 (1991) pp. 6958-6966.
M. F. Holick et al., Transactions of the Association of American Physicians , vol. XCII, 1979, pp. 54-63, "Physiologic Implications of the Formation of Previtamin D in Skin".
M. Takahashi et al., Chemical Abstracts, vol. 110, No. 10, 1989, Columbus, Ohio, Abstract No. 84136v, "Enteric-Soluble Capsule Base Composed of Poly(Ethylene Glycol) or Its Substitutes and Cellulose Acetate Phthalate or Hydroxypropyl Methyl Cellulose Phthalate".
A. W. Norman et al., J. Biol. Chem., vol. 268, No. 19, (1993) pp. 13811-13819, "Structure-Function Studies of 1,25-Dihydroxyvitamin D.sub.3 and the Vitamin D Endocrine System".
Bishop Charles W.
Knutson Joyce C.
Valliere Charles R.
Bone Care International, Inc.
Meier Linda Blair
Moezie Minna
Wang Shengjun
Welch Teresa J.
LandOfFree
Oral 1.alpha.-hydroxyprevitamin D in methods for increasing bloo does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Oral 1.alpha.-hydroxyprevitamin D in methods for increasing bloo, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oral 1.alpha.-hydroxyprevitamin D in methods for increasing bloo will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-469014